Aveed 750 MG/3 ML vial 3ML
Ended Awarded
- Contract number
- SPE2DB25FPRE4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,045
Award facts
- Contract value 100% obligated
- $31,044.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $31,044.90 by the Defense Logistics Agency (DLA) on August 20, 2025. The award covers the supply of AVEED 750 mg/3 ml vials, a testosterone replacement therapy medication. This firm fixed-price delivery order is structured with an ultimate completion date of August 21, 2025, and utilizes no set-aside designation. The contract falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to issue delivery orders for an extensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent performance delivering prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. The company's portfolio includes delivery of specialty pharmaceuticals across multiple therapeutic categories, and this AVEED delivery order represents a continuation of its pharmaceutical distribution services to support military healthcare operations. The DLA's use of the SPE2DB indefinite delivery contract vehicle allows for efficient procurement of required pharmaceutical inventory with predetermined pricing and streamlined ordering processes for government healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FPRE4?
SPE2DB25FPRE4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FPRE4 worth?
The government has obligated $31,045 on SPE2DB25FPRE4.
Is contract SPE2DB25FPRE4 an order under another contract?
Yes. SPE2DB25FPRE4 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRE4 competed?
The extent of competition for SPE2DB25FPRE4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award